Brief: Kiromic Biopharma Inc - On October 21, Issued A 25% Senior Secured Convertible Promissory Note To An Accredited Investor
27/10/2022 21:50
Oct 27 (Reuters) - Kiromic Biopharma Inc KRBP.O :
* KIROMIC BIOPHARMA INC - ON OCTOBER 21, ISSUED A 25% SENIOR
SECURED CONVERTIBLE PROMISSORY NOTE TO AN ACCREDITED INVESTOR
* KIROMIC BIOPHARMA INC - NOTE HAS A PRINCIPAL AMOUNT OF $2
MILLION BEARS INTEREST AT A RATE OF 25% PER ANNUM AND MATURES ON
OCTOBER 21, 2023
Further company coverage: KRBP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kiromic Biopharma
See all newsBrief: Kiromic Biopharma Files For Offering Up To 1 Million Units
Brief: Kiromic Biopharma Applies To List Common Stock On The NYSE American Under Symbol 'KRBP'
Brief: Kiromic Biopharma Advances Deltacel-01 Into Expansion Phase Following Safety Monitoring Committee's Unanimous Recommendation
Brief: Kiromic Biopharma Reports Favorable Results At Six Weeks From Fourth Patient In Deltacel-01 Clinical Trial
Brief: Kiromic BioPharma Adds UPMC as Fourth Deltacel-01 Clinical Trial Site